![Antoine Barraud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Peter Ryser | M | 72 |
AMF Medical SA
![]() AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | 9 jaar |
Peter Gerhardsson | M | - |
AMF Medical SA
![]() AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | - |
John E. Timberlake | M | 59 |
AMF Medical SA
![]() AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | 3 jaar |
Ronald Strässler | M | - |
AMF Medical SA
![]() AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | 5 jaar |
Pim Van Wesel | M | - |
AMF Medical SA
![]() AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | 4 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Zwitserland | 5 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Antoine Barraud
- Persoonlijk netwerk